This article is more than 5 years old. Information may no longer be current.
Top 5 ophthalmology news stories this week
Click Here to Manage Email Alerts
Trending ophthalmology topics this week ranged from the FDA approval of two Tecnis multifocal IOLs from Abbott to the recommendation of the approval of Eylea in Europe for the treatment of macular edema secondary to retinal vein occlusion.
Here are the top 5 most-viewed stories this week:
1. FDA approves two Tecnis multifocal IOLs from Abbott
The FDA approved Abbott’s +2.75 D and +3.25 D Tecnis one-piece multifocal IOLs. Read more
2. Ophthalmic community mourns loss of George O. Waring III
George O. Waring III, MD, FACS, FRCOphth, a surgeon, innovator and mentor, died Jan. 27. Read more
3. Envisia initiates phase 2a clinical trial for glaucoma treatment
Envisia Therapeutics initiated a phase 2a clinical trial to investigate the safety and tolerability of ENV515 in glaucoma patients. Read more
4. Alcon net sales increased to $10.8 billion in 2014
Alcon’s net sales for fiscal year 2014 totaled $10.8 billion, a 3% increase from the previous year. Read more
5. Eylea for macular edema secondary to CRVO, BRVO recommended for approval in EU
The European Committee for Medicinal Products for Human Use recommended the approval of Eylea for the treatment of visual impairment due to macular edema secondary to central or branch retinal vein occlusion. Read more